Saturday - February 28, 2026
Novartis to Build New Radioligand Therapy Site in Denton, Texas, Delivering More Next Generation Treatments to Patients
February 26, 2026
BASEL, Switzerland, Feb. 26 -- Novartis, a pharmaceutical company, issued the following news release on Feb. 25, 2026:

* * *

Novartis to build new radioligand therapy site in Denton, Texas, delivering more next generation treatments to patients

* Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in US

* Site to serve patients in Southern US and add network capacity as RLT expands . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products